$8.90
0.65[7.88%]
At close: Apr 18
$8.90
0[0.00%]
After Hours: 9:01AM EDT
Oncternal Therapeutics
(NASDAQ:ONCT)Oncternal Therapeutics Stock (NASDAQ:ONCT), Insider Trading Activity
Oncternal Therapeutics: Insider buying and selling updated today.
Institutional Shares Held
582.047K
Institutional Percentage Held
9.65%
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 10, 2024 | James Robert Wills | DIRECTOR | 3.086K | $8.96 | $27.65K | BUY | 44.63% | 10K | Apr 08 | View |
| Apr 01, 2024 | James Robert Wills | DIRECTOR | 6.914K | $8.48 | $58.60K | BUY | ∞ | 6.914K | Mar 28 | View |
| Feb 27, 2024 | DAVID HALE | DIRECTOR | 980 | $9.04 | $8.86K | BUY | 3.31% | 30.59K | Feb 23 | View |
| Feb 27, 2024 | James Robert Wills | DIRECTOR | -980 | $9.04 | -$8.86K | SELL | -100.00% | 0 | Feb 23 | View |
| Jun 14, 2023 | Gunnar Kaufmann | CHIEF SCIENTIFIC OFFICER | 28K | $0.35 | $9.82K | BUY | 41.96% | 94.726K | Jun 12 - Jun 14 | View |
| Apr 17, 2023 | JAMES BREITMEYER | CHIEF EXECUTIVE OFFICER | 150K | $0.29 | $43.93K | BUY | 317.28% | 197.277K | Apr 13 - Apr 14 | View |
| Apr 14, 2023 | Salim Yazji | CHIEF MEDICAL OFFICER | 25K | $0.29 | $7.20K | BUY | 17.90% | 164.676K | Apr 12 - Apr 14 | View |
| Apr 14, 2023 | Chase C Leavitt | GENERAL COUNSEL/SECRETARY | 25K | $0.29 | $7.25K | BUY | 30.52% | 106.901K | Apr 12 - Apr 13 | View |
| Apr 14, 2023 | RICHARD VINCENT | CHIEF FINANCIAL OFFICER | 30K | $0.30 | $8.96K | BUY | 23.31% | 158.693K | Apr 13 | View |
| Mar 28, 2022 | RICHARD VINCENT | CHIEF FINANCIAL OFFICER | 5K | $1.44 | $7.21K | BUY | 5.88% | 89.996K | Mar 24 - Mar 28 | View |
| Jan 31, 2022 | RICHARD VINCENT | CHIEF FINANCIAL OFFICER | 12.5K | $1.73 | $21.63K | BUY | 17.24% | 84.996K | Jan 27 - Jan 28 | View |
| Jan 31, 2022 | Chase C Leavitt | GENERAL COUNSEL/SECRETARY | 13.5K | $1.72 | $23.28K | BUY | 43.04% | 44.867K | Jan 27 - Jan 28 | View |
| Jan 31, 2022 | Salim Yazji | CHIEF MEDICAL OFFICER | 10K | $1.69 | $16.90K | BUY | 17.50% | 67.137K | Jan 27 | View |
| Jan 31, 2022 | JAMES BREITMEYER | CHIEF EXECUTIVE OFFICER | 25K | $1.68 | $42.08K | BUY | 112.22% | 47.277K | Jan 27 | View |
| Jul 02, 2021 | DAVID HALE | DIRECTOR | -3.669K | $4.75 | -$17.43K | SELL | -0.50% | 731.498K | Jun 30 | View |
| Jun 15, 2021 | Chase C Leavitt | GENERAL COUNSEL/SECRETARY | 1.5K | $5.45 | $8.18K | BUY | ∞ | 1.5K | Jun 11 | View |
| Sep 02, 2020 | MICHAEL CARTER | 71.429K | $2.10 | $150.00K | PURCHASE | 13789.38% | 71.947K | Sep 01 | View | |
| Jul 23, 2020 | DANIEL KISNER | 10K | $2.38 | $23.82K | PURCHASE | ∞ | 10K | Jul 21 | View | |
| Jul 23, 2020 | HAZEL AKER | 41.972K | $2.38 | $100.00K | PURCHASE | 451.36% | 51.271K | Jul 21 | View | |
FAQ
Is Insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.